New obesity drug candidate tested for safety in first human trial
NCT ID NCT06352437
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 17 times
Summary
This early-stage study tested a new drug called BI 3034701 in 125 healthy men and people with overweight or obesity. The main goal was to see if different doses are safe and how the drug enters the blood. Participants received either the drug or a placebo as an injection under the skin. This was the first time the drug was given to humans, so no treatment benefits were expected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Charité Research Organisation GmbH
Berlin, 10117, Germany
Conditions
Explore the condition pages connected to this study.